These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9009654)

  • 1. Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk.
    Schäfer-Korting M; Blechschmidt J; Korting HC
    Mycoses; 1996; 39(9-10):329-39. PubMed ID: 9009654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN; Samaranayake LP
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
    Austin NC; Darlow B
    Cochrane Database Syst Rev; 2004; (1):CD003478. PubMed ID: 14974017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
    Young GA; Bosly A; Gibbs DL; Durrant S
    Eur J Cancer; 1999 Aug; 35(8):1208-13. PubMed ID: 10615231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Patton LL; Bonito AJ; Shugars DA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of oropharyngeal candidiasis in HIV-positive patients.
    Greenspan D
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S51-5. PubMed ID: 7915732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.
    Lumbreras C; Cuervas-Mons V; Jara P; del Palacio A; Turrión VS; Barrios C; Moreno E; Noriega AR; Paya CV
    J Infect Dis; 1996 Sep; 174(3):583-8. PubMed ID: 8769617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
    Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice.
    Taudorf EH; Jemec GBE; Hay RJ; Saunte DML
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1863-1873. PubMed ID: 31287594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole versus nystatin in the treatment of oral candidosis.
    Blomgren J; Berggren U; Jontell M
    Acta Odontol Scand; 1998 Aug; 56(4):202-5. PubMed ID: 9765010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
    Fan S; Liu X; Wu C; Xu L; Li J
    Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
    Ellepola AN; Joseph BK; Samaranayake LP; Bandara HM; Khan ZU
    J Investig Clin Dent; 2016 May; 7(2):149-57. PubMed ID: 25388637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
    White DJ; Johnson EM; Warnock DW
    Genitourin Med; 1993 Apr; 69(2):112-4. PubMed ID: 8389723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin.
    Blyth CC; Barzi F; Hale K; Isaacs D
    J Paediatr Child Health; 2012 Sep; 48(9):846-51. PubMed ID: 22970680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient therapy of HIV-associated oral and oesophageal candidosis.
    Ustianowski AP; Leake H; Evans S
    Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifungal topical therapy in oral chronic candidosis. A comparative study.
    Lopez-De-Blanc SA; Salati-De-Mugnolo N; Femopase FL; Benitez MB; Morelatto RA; Astrada-De-Verde L; Masih D
    Med Oral; 2002; 7(4):260-70. PubMed ID: 12134127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.